Navigation Links
Fruit fly research set to revolutionize study of birth defects

A Queen's University study of fruit flies that may revolutionize the way birth defects are studied has identified the genes affected by a widely-prescribed drug known to cause birth defects.

Methotrexate (MTX), a popular cancer-fighting drug also used to treat psoriasis, ectopic pregnancies, rheumatoid arthritis, and lupus, lasts a long time in the body and causes birth defects in children from women who have it in their systems. The study of the drug's effect on fruit flies has allowed Queen's researchers including graduate student Joslynn Affleck to identify the genes on which the drug acts.

"We hope that through this model system we can provide insight into mammalian birth defects, which may be expected to increase in frequency in the future, due to the recent elevated use of MTX," says Affleck.

Many of the genes found to be affected by MTX are involved in cell cycle regulation, signal transduction, transport, defense response, transcription, or various aspects of metabolism.

"This study shows that MTX treatment has multiple targets," says Affleck. "And this provides us with a novel invertebrate model for the study of drugs that cause birth defects." The findings, funded by NSERC, are set to be published by Toxicological Sciences in the New Year.

"This is not a journal in the habit of publishing insect studies," notes biologist Dr. Virginia Walker, who co-authored the study. "The neat thing about this work is that fruit flies treated with this drug show 'birth defects' that are hauntingly similar to birth defects in human babies. Babies have bent limbs, tufts of hair and bulging eyes and the fruit flies have bent legs (and wings), tufts of bristles and rough eyes."

While identifying this gene array is significant in its own right, the successful use of fruit flies in this kind of study is a revelation to the researchers who view it as an efficient model for the initial testing of "rescue" therapies to try to prevent birth defects. Scientists can study the effect of the drug on the genes of as many as three generations of fruit flies in a month using readily available scientific tools, speeding up study times while keeping costs low.

"It also adds to the growing list of roles fruit flies can take," says Walker. Fruit flies are already used as models for aging, neural disease and cancer.


'"/>

Source:Queen's University


Related biology news :

1. X-Ray Beams And Fruit Fly Flight Simulator Aid Scientists View Of Muscle Power
2. Fruit fly studies open new window on cancer research
3. How Fruitflies Know Its Time for Lunch
4. Fruit flys beating heart helps identify human heart disease genes
5. Fruit fly reveals a potential connection between dementia and cancer
6. Fruit fly dating game provides clues to our reproductive prowess
7. Fruit fly aggression studies have relevance to humans, animals
8. Psst! Coffee drinkers: Fruit flies have something to tell you about caffeine
9. Fruit fly study identifies gene mutation that regulates sensitivity to alcohol
10. Fruit flies and global warming -- Some like it hot
11. Fruit fly gene research may shed light on human disease processes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2016)... , España y TORONTO , 19 de diciembre ... Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un ... en varios tipos de tumor en 2017, con múltiples sitios previstos ... ... clase con objetivo en el factor inhibidor de leucemia (LIF), una ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December ... leading global financial services provider, today announced an agreement with ... behavioural biometrics, to join forces. The partnership will enable clients ... strategies in compliance with local data protection regulation. ... In order to ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... MD (PRWEB) , ... January 18, 2017 , ... ... the National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, ... “scoreable” element of grant applications subject to the existing policy. AMIA recommended that ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, will feature data from two clinical ... 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, ... Napabucasin is an orally-administered investigational agent designed to ... Cancer stem cells (CSCs) possess the property of stemness ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), the scientific staff ... past year and is planned for further growth in 2017. Extractable & Leachable ...
Breaking Biology Technology: